The leading goal was to detect suited analytical targets by examining human hepatocyte incubation samples with significant-resolution mass spectrometry (HRMS) and to verify the final results in authentic urine specimens and to find out AB-FUBINACA's metabolic balance in human liver microsomes and in comparison hepatocyte and urine success with in s